Hantz Financial Services Inc. Takes $3.03 Million Position in GSK plc (NYSE:GSK)

Hantz Financial Services Inc. bought a new position in GSK plc (NYSE:GSK) in the 2nd quarter, according to its most recent filing with the Securities & Exchange Commission. The fund bought 78,745 shares of the pharmaceutical company’s stock, valued at approximately $3,032,000.

A number of other institutional investors have also added to or reduced their stakes in GSK. Register Financial Advisors LLC purchased a new position in shares of GSK in the 1st quarter worth about $31,000. Richardson Financial Services Inc. bought a new stake in GSK in the 4th quarter worth approximately $40,000. Newbridge Financial Services Group Inc. purchased a new stake in GSK in the first quarter worth approximately $49,000. Triad Wealth Partners LLC bought a new position in GSK during the second quarter valued at approximately $49,000. Finally, Jones Financial Companies Lllp raised its stake in shares of GSK by 23.1% during the fourth quarter. Jones Financial Companies Lllp now owns 1,633 shares of the pharmaceutical company’s stock worth $61,000 after acquiring an additional 306 shares in the last quarter. Institutional investors own 15.74% of the company’s stock.

Wall Street Analysts Forecast Growth

A number of brokerages have recently issued reports on GSK. Argus raised shares of GSK to a “strong-buy” rating in a research note on Wednesday, August 7th. Berenberg Bank upgraded GSK to a “strong-buy” rating in a report on Thursday, June 20th. Barclays raised GSK to a “hold” rating in a research note on Tuesday. Jefferies Financial Group lifted their price target on GSK from $52.50 to $53.00 and gave the stock a “buy” rating in a research note on Tuesday, July 2nd. Finally, Citigroup raised GSK to a “strong-buy” rating in a research note on Monday, June 24th. Four analysts have rated the stock with a hold rating, two have issued a buy rating and four have issued a strong buy rating to the stock. According to MarketBeat.com, GSK presently has an average rating of “Buy” and an average price target of $50.00.

GSK Stock Up 0.4 %

Shares of NYSE:GSK opened at $43.91 on Friday. GSK plc has a 1 year low of $33.67 and a 1 year high of $45.92. The company has a debt-to-equity ratio of 0.99, a current ratio of 0.82 and a quick ratio of 0.58. The stock’s 50-day moving average is $40.04 and its 200 day moving average is $41.56. The company has a market cap of $91.00 billion, a PE ratio of 15.90, a P/E/G ratio of 1.32 and a beta of 0.64.

GSK Increases Dividend

The firm also recently announced a quarterly dividend, which will be paid on Thursday, October 10th. Investors of record on Friday, August 16th will be issued a dividend of $0.3843 per share. This represents a $1.54 dividend on an annualized basis and a dividend yield of 3.50%. The ex-dividend date of this dividend is Friday, August 16th. This is an increase from GSK’s previous quarterly dividend of $0.38. GSK’s dividend payout ratio is currently 54.71%.

GSK Company Profile

GSK plc, together with its subsidiaries, engages in the research, development, and manufacture of vaccines, and specialty and general medicines to prevent and treat disease in the United Kingdom, the United States, and internationally. It operates through two segments, Commercial Operations and Total R&D.